These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15512956)

  • 1. AIDS-related cytomegalovirus retinitis: lessons from the laboratory.
    Dix RD; Cousins SW
    Curr Eye Res; 2004; 29(2-3):91-101. PubMed ID: 15512956
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus Retinitis in infancy.
    Wren SM; Fielder AR; Bethell D; Lyall EG; Tudor-Williams G; Cocker KD; Mitchell SM
    Eye (Lond); 2004 Apr; 18(4):389-92. PubMed ID: 15069436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus retinitis in patients with AIDS: current status.
    Nichols TT
    Med J Aust; 1996 Apr; 164(7):446. PubMed ID: 8609866
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue.
    Kercher L; Mitchell BM
    J Infect Dis; 2000 Sep; 182(3):652-61. PubMed ID: 10950756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibody to gB2 human cytomegalovirus does not prevent reactivation in patients with human immunodeficiency virus infection.
    Rasmussen L; Cowan CM
    J Gen Virol; 2003 Jul; 84(Pt 7):1853-1857. PubMed ID: 12810879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional analysis of immune response genes during pathogenesis of cytomegalovirus retinitis in mice with murine acquired immunodeficiency syndrome.
    Carter JJ; Gardner JM; Poling BP; Welch MM; Nemeno JGE; Houghton JE; Dix RD
    PLoS Pathog; 2020 Nov; 16(11):e1009032. PubMed ID: 33156834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment: failure of HAART to reconstitute CMV-specific protective immunity.
    Jacobson MA
    AIDS Read; 2005 Apr; 15(4):188. PubMed ID: 15844239
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of cytomegalovirus retinitis in patients with human immunodeficiency virus following negative initial screening examination results.
    Chen J; Ausayakhun S; Tangmonkongvoragul C; Ausayakhun S; Jirawison C; Margolis TP; Keenan JD
    Arch Ophthalmol; 2012 Apr; 130(4):527-9. PubMed ID: 22491928
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced frequency of murine cytomegalovirus retinitis in C57BL/6 mice correlates with low levels of suppressor of cytokine signaling (SOCS)1 and SOCS3 expression within the eye during corticosteroid-induced immunosuppression.
    Alston CI; Dix RD
    Cytokine; 2017 Sep; 97():38-41. PubMed ID: 28558309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination HIV therapy and opportunistic infections of the eye in people with AIDS.
    Ash S
    Br J Ophthalmol; 1998 Sep; 82(9):981-2. PubMed ID: 9893581
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma.
    Dix RD; Cousins SW
    Curr Eye Res; 2004; 29(2-3):173-80. PubMed ID: 15512964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in patients with AIDS-related cytomegalovirus retinitis in Myanmar.
    Tun N; Smithuis FM; London N; Drew WL; Heiden D
    Clin Infect Dis; 2014 Dec; 59(11):1650-1. PubMed ID: 25121775
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of cytomegalovirus retinitis in AIDS.
    Dhillon B
    Br J Ophthalmol; 1994 Jan; 78(1):66-9. PubMed ID: 8110704
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
    Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
    Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.